Protara's IV Choline Chloride Receives FDA Fast Track Designation for Patients on Parenteral Support
Express News | Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), MoonLake Immunotherapeutics (MLTX) and Protara Therapeutics (TARA)
Opaleye Management Inc. Reduces Stake in Protara Therapeutics Inc.
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
Protara Therapeutics Announces Results From THRIVE-1, A Study Evaluating The Prevalence Of Choline Deficiency And Liver Injury In Patients Dependent On Parenteral Support
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Ultratech : $Focus Universal (FCUV.US)$
Stock_Drift OP Ultratech : I have $Endeavour Silver (EXK.US)$ and up .09